Scientists have long believed that glioblastoma multiforme, the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. Researchers found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons.
A new drug could help increase the effectiveness of radiation therapy for patients with glioblastoma multiforme, the most deadly form of brain cancer. The ATM kinase inhibitor, in combination with radiation therapy, helped significantly extend survival rates in mouse models of GBM.
Researchers discover a link between brain development and the BRAC1, a gene associated with breast cancer.
Researchers find high levels of progesterone can kill glioblastoma cells and inhibit brain tumor growth.
Researchers have discovered a new method to ramp up the conversion of skin cells to dopamine neurons.
A new study reveals molecular differences between how the African and Asian strains of Zika virus infect neural progenitor cells.
Researchers believe new study may help improve understanding of the genetic causes of microcephaly and other neurodevelopmental disorders.
Researchers have been able to successfully boost the regeneration of mature nerve cells in the spinal cord of adult mice following spinal cord injury.
A strain of a bacteria commonly associated with food poisoning could prove an unlikely ally in the battle against glioblastoma brain cancer, a new study reports.
Researchers are turning to supercomputers in the quest to discover new treatments and targets for cancers.
PPCA treatment shown to provide therapeutic benefit in mouse models of hemophagocytic lymphohistiocytosis and multiple sclerosis.
Researchers use gene editing to generate aggressive glioblastoma multiforme brain tumors in the lab. The model, researchers say, could be used to track the progression of tumors and develop personalized therapies for patients.